Hidradenitis suppurativa management using tumor necrosis factor inhibitors in patients younger than 18 years: A series of 12 cases - 19/06/20
, Ziad Reguiai, MD b, Aude Roussel, MD a, Pierre-André Bécherel, MD, PhD cfor the
Groupe d'Etudes Multicentriques (GEM) ResoVerneuil
| Funding sources: None. |
|
| Disclosure: Dr Fougerousse reports relationships with AbbVie, Janssen, and Novartis. Dr Reguiai reports relationships with AbbVie, Janssen, and Novartis. Dr Bécherel reports relationships with AbbVie, Janssen, Novartis, and InflaRx. Dr Roussel has no conflicts of interest to declare. |
|
| IRB approval status: Not applicable. |
Vol 83 - N° 1
P. 199-201 - luglio 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
